Mohammad Amin Seyedian

Suggest Changes
Learn More
BACKGROUND To assess the short-term efficacy and safety of corneal collagen cross-linking (CXL) in preventing the progression of keratoconus (KCN). MATERIALS AND METHODS This randomized controlled(More)
To compare the 6-month results of two formulations of Riboflavin provided by Sina Darou, Iran, and Uznach, Switzerland, in corneal collagen cross-linking (CXL) for keratoconus patients. Considering(More)